NEAT1 downregulation, via the miR-155/Tim-3 pathway, inhibits CD8+T cell apoptosis and enhances cytotoxicity against HCC, highlighting its potential as an immunotherapy target. Here, NEAT1 is linked to hepatocellular carcinoma.